Your session is about to expire
← Back to Search
Other
Nano-Pulse Stimulation (NPS) Treated Lesion for Skin Abnormalities
N/A
Waitlist Available
Research Sponsored by Pulse Biosciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60-days post-last nps treatment
Awards & highlights
Study Summary
Primary study objective is to evaluate the optimization of Nano-Pulse Stimulation (NPS) energy settings for lesion clearance of Sebaceous Hyperplasia (SH) lesions from facial areas of healthy adult subjects.
Eligible Conditions
- Skin Abnormalities
- Sebaceous Hyperplasia
- Skin Lesions
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 60-days post-last nps treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60-days post-last nps treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
SH Lesion Clearance Rate
Trial Design
1Treatment groups
Experimental Treatment
Group I: Nano-Pulse Stimulation (NPS) Treated LesionExperimental Treatment1 Intervention
Nano-Pulse Stimulation of target lesion.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nano-Pulse Stimulation (NPS)
2017
N/A
~60
Find a Location
Who is running the clinical trial?
Pulse Biosciences, Inc.Lead Sponsor
9 Previous Clinical Trials
667 Total Patients Enrolled
2 Trials studying Skin Abnormalities
132 Patients Enrolled for Skin Abnormalities
Richard A Nuccitelli, PhDStudy ChairPulse Biosciences, Inc.
2 Previous Clinical Trials
233 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger